JCB logo
MBL International Tel: 800.200.5459 CLICK HERE
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 21 May 2001. doi:10.1083/jcb.153.5.917
This Article
Right arrow Full Text
Right arrow PDF (Full Text)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Muraoka, R. S.
Right arrow Articles by Arteaga, C. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Muraoka, R. S.
Right arrow Articles by Arteaga, C. L.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© The Rockefeller University Press, 0021-9525/2001/5/917/ $5.00
The Journal of Cell Biology, Volume 153, Number 5, May 28, 2001 917-932


Original Article

Cyclin-dependent Kinase Inhibitor p27Kip1 Is Required for Mouse Mammary Gland Morphogenesis and Function

Rebecca S. Muraokaa, Anne E.G. Lenferinkc, Jean Simpsonb,e, Dana M. Brantleyc, L. Renee Roebuckc, F. Michael Yakesc, and Carlos L. Arteagaa,c,d,e
a Department of Cell Biology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232
b Department of Pathology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232
c Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee 37232
d Department of Veteran Affairs Medical Center, Nashville, Tennessee 37232
e Vanderbilt-Ingram Cancer Center, Nashville, Tennessee 37232

Correspondence to: Carlos L. Arteaga, Div. of Oncology, Vanderbilt University School of Medicine, 22nd Ave. S., 1956 TVC, Nashville, TN 37232-5536. Tel:(615) 936-3524 Fax:(615) 936-1790 E-mail:carlos.arteaga{at}mcmail.vanderbilt.edu.

We have studied the role of the cyclin-dependent kinase (Cdk) inhibitor p27Kip1 in postnatal mammary gland morphogenesis. Based on its ability to negatively regulate cyclin/Cdk function, loss of p27 may result in unrestrained cellular proliferation. However, recent evidence about the stabilizing effect of p27 on cyclin D1–Cdk4 complexes suggests that p27 deficiency might recapitulate the hypoplastic mammary phenotype of cyclin D1–deficient animals. These hypotheses were investigated in postnatal p27-deficient (p27-/-), hemizygous (p27+/-), or wild-type (p27+/+) mammary glands. Mammary glands from p27+/- mice displayed increased ductal branching and proliferation with delayed postlactational involution. In contrast, p27-/- mammary glands or wild-type mammary fat pads reconstituted with p27-/- epithelium produced the opposite phenotype: hypoplasia, low proliferation, decreased ductal branching, impaired lobuloalveolar differentiation, and inability to lactate. The association of cyclin D1 with Cdk4, the kinase activity of Cdk4 against pRb in vitro, the nuclear localization of cyclin D1, and the stability of cyclin D1 were all severely impaired in p27-/- mammary epithelial cells compared with p27+/+ and p27+/- mammary epithelial cells. Therefore, p27 is required for mammary gland development in a dose-dependent fashion and positively regulates cyclin D–Cdk4 function in the mammary gland.

Key Words: p27, mammary gland, cyclin D1, growth, apoptosis


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents